Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford Sciences Innovation Plc (OSI) announces two new Board-level appointments, with experienced technology entrepreneur Charles Conn joining as Chief Executive and former Google CFO Patrick Pichette joining as Chairman.

Circuit board © Shutterstock

OSI provides capital and scaling expertise to businesses driven by intellectual property developed in Oxford University’s Mathematical, Physical, Life Sciences Division and Medical Sciences Division, with a core ambition to bring the very best of the University’s scientific research to the market. 

Charles Conn will take up his post on March 1st 2019 replacing outgoing CEO Dave Norwood, who retires. Patrick Pichette will join the Board as a Non-Executive Director on 1 March 2019 before becoming Chairman on 1 July 2019. OSI’s existing Chairman Peter Davies intends to move to a Non-Executive Director position to continue to support the company through its next stage of development.

Read more (University of Oxford website)

Similar stories

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.

Major new NIHR Global Health Research Unit to focus on data science and genomic surveillance of antimicrobial resistance

The Centre for Genomic Pathogen Surveillance, part of the Big Data Institute at the University of Oxford, has been awarded funding worth £7m for their work as an NIHR Global Health Research Unit (GHRU) for the next five years. The Centre’s research and capacity building work focuses on delivering genomics and enabling data for the surveillance of antimicrobial resistance (AMR).

Gero Miesenböck awarded Horwitz Prize for foundational work on Optogenetics

Congratulations to Professor Gero Miesenböck (Department of Physiology, Anatomy and Genetics) who is to be awarded the 2022 Louisa Gross Horwitz Prize, together with Professors Karl Deisseroth and Peter Hegemann, for research that laid the foundation for the field of optogenetics.

Oxford’s clinical staff awarded OAHP funding for research skills training

£73,000 of professional development grants are being awarded to Oxford’s nurses, midwives, allied health professionals and research practitioners to develop skills that will support them to research new and improved ways of delivering healthcare to patients and service users.

Professor Dame Sue Black joins DPAG as Visiting Professor of Forensic Anatomy

The Department welcomes Professor Dame Sue Black DBE OBE FRSE FBA FRAI FRSB ChFA, Baroness Black of Strome and one of the world’s leading forensic scientists, as our Visiting Professor of Forensic Anatomy.